REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Valueadd Pharma (By Dr. Murpani) sp. k. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Pharmaceutical Preparation Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Department Stores | Scientific Research and Development Services | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Packaging and Labeling Services
Full name: Valueadd Pharma (By Dr. Murpani) sp. k. Profile Updated: May 31, 2024
Buy our report for this company USD 19.99 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Valueadd Pharma (By Dr. Murpani) sp. k. is an enterprise located in Poland, with the main office in Warsaw. It operates in the Research and Development in Biotechnology (except Nanobiotechnology) sector. It was established on March 07, 2017. From the latest financial highlights, Valueadd Pharma (By Dr. Murpani) sp. k. reported a net sales revenue drop of 12.18% in 2024. Its total assets grew by 7.78% over the same period. In, 2024, the company’s net profit margin increased by 17.43%.

Headquarters
Ul. Domaniewska 47/10
Warsaw; Mazowieckie; Postal Code: 02-672

Contact Details: Purchase the Valueadd Pharma (By Dr. Murpani) sp. k. report to view the information.

Basic Information
Financial Auditors:
Purchase the Valueadd Pharma (By Dr. Murpani) sp. k. report to view the information.
Incorporation Date:
March 07, 2017
Key Executives
Purchase this report to view the information.
Associate Partner
Purchase this report to view the information.
Limited Partner
Ownership Details
Purchase this report to view the information.
100%
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Valueadd Pharma (By Dr. Murpani) sp. k. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-12.18%▼
Total operating revenue
-12.41%▼
Operating profit (EBIT)
-9.16%▼
EBITDA
-11.89%▼
Net Profit (Loss) for the Period
8.49%▲
Total assets
7.78%▲
Total equity
8.44%▲
Operating Profit Margin (ROS)
3.24%▲
Net Profit Margin
17.43%▲
Return on Equity (ROE)
0.05%▲
Quick Ratio
4.79%▲
Cash Ratio
5.48%▲

To view more information, Request a demonstration of the EMIS service

USD 19.99
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo